Mesothelioma News

When Marianne M. Geier was diagnosed with malignant mesothelioma, the rare form of cancer caused by exposure to asbestos, she was asked where she might have been exposed to the carcinogenic material. It did not take long for her to remember the 1958-to-1959 school year when she worked as a substitute teacher at South High

Read More

In 2016, Frank and Cynthia Hart filed a personal injury lawsuit against several different companies, accusing them of responsibility for Mr. Hart’s malignant mesothelioma. After a jury heard the case, they awarded over $5 million to the couple plus an allocation of prior settlements to potential future wrongful death claims. One of the defendants, Keenan

Read More

Print shop maintenance is not likely to be found on a list of dangerous occupations, yet it is the equipment involved in the job that Thomas Pearson’s family blames for his malignant mesothelioma death. Mr. Pearson died of the rare asbestos-related disease at the age of 72 after years of cleaning and repairing the Linotype

Read More

Treatment for malignant mesothelioma depends upon the patient’s specific condition as well as their personal goals. In most cases they are offered a combination of chemotherapy, surgery and radiation therapy that together extend survival and minimize discomfort and pain.  Despite the availability of rehabilitation following these treatments, only a small percentage of patients are offered this

Read More

Malignant mesothelioma is a disease that is typically associated with older men who either worked in high-heat settings or who served in the military during World War II and the years afterward. This is because the rare and deadly form of cancer is caused by exposure to asbestos, the carcinogenic mineral once used to insulate

Read More

Most patients diagnosed with malignant pleural mesothelioma are treated with a multi-modality protocol that combines surgery, chemotherapy and radiation therapy. Each modality’s use is adjusted based upon the specifics of the patient’s condition, and particular care is used with radiation because of its potential for damaging healthy tissue. But a collaborative group of radiology experts

Read More

It’s been nearly three years since a California jury awarded Richard Booker’s family $22 million in damages following his death from malignant mesothelioma.  in the years since, one of the two companies named as defendants has worked to have that decision reversed. Despite Imerys Talc America’s multi-part appeal, the Court of Appeals of California confirmed the

Read More

When asbestos companies are found guilty of negligence in mesothelioma lawsuits, it costs them enormous amounts of money, so defendants go to great lengths to disprove what victims have to say. Since most cases rely on testimony from expert witnesses, asbestos companies frequently argue against allowing them to tell what they know. Fortunately, judges have

Read More

For patients diagnosed with malignant pleural mesothelioma, the over-arching question is always how much time they have left to them. Though physicians can never provide an exact number of days or months, researchers are identifying specific indicators that provide insight into which patients are likely to have better rates of survival and which will likely

Read More

The fight against malignant mesothelioma is being waged in hospitals all around the world, and steps forward taken by European physicians are watched closely in the United States. Recently, a task force of the most notable experts in the field published revised best practices for the treatment of malignant mesothelioma. It is the first update

Read More

In 2018, chemical engineer Dr. James L. Gaddy was diagnosed with malignant mesothelioma, and shortly thereafter he filed suit against Ethyl Corporation and other defendants, accusing them of negligence in having exposed him to asbestos. A trial court agreed, assigning the companies $7.5 million in damages and attributing one-third of the financial responsibility to Ethyl.

Read More

Though malignant pleural mesothelioma remains one of the most challenging types of cancer to treat, physicians continue to refine surgical approaches and improve patient outcomes. A recently conducted retrospective study has confirmed the benefits of extended pleurectomy decortication as a surgical approach in the treatment of the rare, asbestos-related disease, indicating that patients who opt

Read More

Immunotherapy represents real hope in the fight against malignant mesothelioma, as well as in other types of cancer. A presentation delivered at the 5th Annual International Congress on Immunotherapies in Cancer reinforced the sense of optimism, as a top researcher indicated improvements in the results being seen.

Read More

A diagnosis of malignant mesothelioma changes everything. While its most immediate and important impact is the threat to health, it also affects the way that victims prioritize, how they move through their lives, and how they relate to those around them. All too often the important choices they make – including where to get treated

Read More

In the face of a terminal illness, many patients seek alternative treatments, and this is as true for malignant mesothelioma as for any other type of intractable cancer. Some of the solutions being offered are little better than snake oil – witness the fruitless search for a miracle that actor Steve McQueen pursued when he

Read More

Mesothelioma is caused by exposure to asbestos, and in the vast majority of cases the people diagnosed with the disease had no idea they were at risk. This is especially the case for those exposed to asbestos carried into their homes by spouses or parents. An example of this tragic scenario was the subject of

Read More

Malignant mesothelioma is traditionally associated with occupational exposures to asbestos in jobs involving high-heat environments. As asbestos use has diminished in those settings, there had been hope that the incidence of the rare asbestos-related disease would also fall. But recent findings point to concerning new trends regarding the use of talc, a mineral frequently found

Read More

The use of state-of-the-art medications holds tremendous hope for patients diagnosed with malignant mesothelioma, but there are no sure things and no silver bullets. These new drugs have not been fully tested and can lead to deadly side effects. A recent report published by Australian researchers revealed that a patient treated with one of the

Read More

Though malignant mesothelioma has a well-deserved reputation as a fatal form of cancer, some patients survive far longer than others, with some living decades beyond the time that their disease is diagnosed. Identifying the distinguishing factors that make patients more or less vulnerable to dying of the disease has long been a priority for researchers.

Read More

ONCOS-102 is a virus-based cancer therapy being developed by Targovax for the treatment of patients with solid tumors like malignant mesothelioma. The company has just released an 18-month status update on patients provided a combination of ONCOS-102 with chemotherapy, revealing that median Overall Survival will be at least 18.2 months for first-line patients compared to

Read More